These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 863458)

  • 1. Use of normal daughters' and sisters' creatine kinase levels in estimating heterozygosity in Duchenne muscular dystrophy.
    Emery AE; Holloway S
    Hum Hered; 1977; 27(2):118-26. PubMed ID: 863458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Estimation of the probability of heterozygosity in Duchenne-type progressive muscular dystrophy].
    Guízar Vázquez J; Navarrete Cadena C; Rico R; Mora G; Zavala C
    Bol Med Hosp Infant Mex; 1981; 38(1):23-33. PubMed ID: 7284070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Identification of the carrier state in the severe recessive X-linked muscular dystrophy (Duchenne type). I. Assay of activated serum creatine kinase activity in serum (author's transl)].
    Rotthauwe HW; Kowalewski S
    Z Kinderheilkd; 1973 Nov; 115(4):333-42. PubMed ID: 4591596
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of normal daughters' CPK levels in the estimation of heterozygosity risks in X-linked muscular dystrophies.
    Zatz M; Frota-Pessoa O; Peres CA
    Hum Hered; 1975; 25(5):354-9. PubMed ID: 1222942
    [No Abstract]   [Full Text] [Related]  

  • 5. X-linked Duchenne muscular dystrophy in an unusual family with manifesting carriers.
    Kaladhar Reddy B; Anandavalli TE; Reddi OS
    Hum Genet; 1984; 67(4):460-2. PubMed ID: 6490012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The manifesting carrier in Duchenne muscular dystrophy.
    Moser H; Emery AE
    Clin Genet; 1974; 5(4):271-84. PubMed ID: 4854942
    [No Abstract]   [Full Text] [Related]  

  • 7. DUCHEN: an interactive computer program for calculating heterozygosity (carrier) risks in X-linked recessive lethal diseases, and its application in Duchenne muscular dystrophy.
    Andrews DF; Brasher PM; Manchester KE; Percy ME; Rusk AC; Soltan HC; Trueman DW
    Am J Med Genet; 1986 Oct; 25(2):211-8. PubMed ID: 3777018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of serum creatine kinase estimation with short tandem repeats based linkage analysis in carriers and affected children of Duchenne muscular dystrophy.
    Hashim R; Shaheen S; Ahmad S; Sattar A; Khan FA
    J Ayub Med Coll Abbottabad; 2011; 23(1):125-8. PubMed ID: 22830166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic counseling in Becker type X-linked muscular dystrophy. II: Practical considerations.
    Grimm T
    Am J Med Genet; 1984 Aug; 18(4):719-23. PubMed ID: 6486170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duchenne-like muscular dystrophy in two sisters with normal karyotypes: evidence for autosomal recessive inheritance.
    Somer H; Voutilainen A; Knuutila S; Kaitila I; Rapola J; Leinonen H
    Clin Genet; 1985 Aug; 28(2):151-6. PubMed ID: 4042397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of discriminant analysis of serum creatine kinase levels for detection of heterozygote carriers of Duchenne muscular dystrophy].
    Krasil'nikov VV; Labeznik TA; Shilov LA
    Genetika; 1987 Jan; 23(1):176-9. PubMed ID: 3817468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the carrier state in X-linked recessive (Duchenne) muscular dystrophy.
    Thomson WH; Sweetin JC; Hilditch TE
    Clin Chim Acta; 1975 Sep; 63(3):383-94. PubMed ID: 240524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duchenne muscular dystrophy and idiopathic hyperCKemia in a family causing confusion in genetic counselling.
    Bushby K; Goodship J; Haggerty D; Heald A; Walls T
    Am J Med Genet; 1996 Dec; 66(2):237-8. PubMed ID: 8958338
    [No Abstract]   [Full Text] [Related]  

  • 14. Muscular dystrophy. Part II: Serum enzymes in relatives of cases of the Duchenne muscular dystrophy.
    Narayanan I; Ramakrishna Rao P; Balakrishnan S; Subrahmanyam K
    Indian J Med Res; 1974 Apr; 62(4):605-11. PubMed ID: 4435869
    [No Abstract]   [Full Text] [Related]  

  • 15. Creatine-phosphokinase (CPK) activity in relatives of patients with X-linked muscular dystrophies: a Brazilian study.
    Zatz M; Frota-Pessoa O; Levy JA; Peres CA
    J Genet Hum; 1976 Jun; 24(2):153-68. PubMed ID: 965952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Carrier detection and gene analysis in a Duchenne muscular dystrophy family].
    Lu FM
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Aug; 23(4):231-3, 255. PubMed ID: 1979269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A survey of manifesting carriers of Duchenne and Becker muscular dystrophy in Wales.
    Norman A; Harper P
    Clin Genet; 1989 Jul; 36(1):31-7. PubMed ID: 2766561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of serum creatine kinase, pyruvate kinase, and genetic linkage for carrier detection in Duchenne and Becker dystrophy.
    Hyser CL; Griggs RC; Mendell JR; Polakowska R; Quirk S; Brooke MH; Fenichel GM; Doherty RA
    Neurology; 1987 Jan; 37(1):4-10. PubMed ID: 2879259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carrier detection in X-linked muscular dystrophy.
    Walton JN
    J Genet Hum; 1969 Oct; 17(3):497-510. PubMed ID: 5387424
    [No Abstract]   [Full Text] [Related]  

  • 20. X linked muscular dystrophy with contractures.
    Johnston AW; McKay E
    J Med Genet; 1986 Dec; 23(6):591-5. PubMed ID: 3806639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.